1. Home
  2. CGTX vs TTEC Comparison

CGTX vs TTEC Comparison

Compare CGTX & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • TTEC
  • Stock Information
  • Founded
  • CGTX 2007
  • TTEC 1982
  • Country
  • CGTX United States
  • TTEC United States
  • Employees
  • CGTX N/A
  • TTEC N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • TTEC Retail: Computer Software & Peripheral Equipment
  • Sector
  • CGTX Health Care
  • TTEC Technology
  • Exchange
  • CGTX Nasdaq
  • TTEC Nasdaq
  • Market Cap
  • CGTX 158.8M
  • TTEC 183.7M
  • IPO Year
  • CGTX 2021
  • TTEC 1996
  • Fundamental
  • Price
  • CGTX $1.74
  • TTEC $3.50
  • Analyst Decision
  • CGTX Strong Buy
  • TTEC Hold
  • Analyst Count
  • CGTX 3
  • TTEC 2
  • Target Price
  • CGTX $2.83
  • TTEC $3.50
  • AVG Volume (30 Days)
  • CGTX 2.1M
  • TTEC 291.4K
  • Earning Date
  • CGTX 11-12-2025
  • TTEC 11-06-2025
  • Dividend Yield
  • CGTX N/A
  • TTEC N/A
  • EPS Growth
  • CGTX N/A
  • TTEC N/A
  • EPS
  • CGTX N/A
  • TTEC N/A
  • Revenue
  • CGTX N/A
  • TTEC $2,144,663,000.00
  • Revenue This Year
  • CGTX N/A
  • TTEC N/A
  • Revenue Next Year
  • CGTX N/A
  • TTEC $0.47
  • P/E Ratio
  • CGTX N/A
  • TTEC N/A
  • Revenue Growth
  • CGTX N/A
  • TTEC N/A
  • 52 Week Low
  • CGTX $0.22
  • TTEC $2.67
  • 52 Week High
  • CGTX $3.83
  • TTEC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 51.92
  • TTEC 45.73
  • Support Level
  • CGTX $1.67
  • TTEC $3.32
  • Resistance Level
  • CGTX $2.00
  • TTEC $3.64
  • Average True Range (ATR)
  • CGTX 0.16
  • TTEC 0.19
  • MACD
  • CGTX 0.02
  • TTEC 0.01
  • Stochastic Oscillator
  • CGTX 59.48
  • TTEC 34.21

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

Share on Social Networks: